See analyst estimates and all valuation multiples for Pharmacies
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $153B | 0.4x | 9.9x | |
| $38.2B | 0.3x | 10.0x | |
| $26.4B | 7.8x | 32.7x | |
| $10.3B | 1.2x | 25.4x | |
| $7.7B | 1.0x | 10.6x | |
| $7.6B | 1.8x | 31.7x | |
| $7.6B | 0.2x | 3.5x | |
| $6.4B | 0.5x | 11.0x | |
| $5.7B | 0.7x | 9.1x | |
| $5.1B | 0.7x | 11.5x | |
| $5.0B | 1.8x | 13.5x | |
| $4.6B | 1.7x | 10.5x | |
| $4.2B | 0.7x | 9.4x | |
| $3.8B | 0.2x | 5.8x | |
| $3.7B | 1.0x | 9.1x | |
| $3.7B | 0.4x | 8.3x | |
| $3.6B | 0.6x | 8.6x | |
| $3.5B | 0.6x | 7.9x | |
| $3.0B | 0.9x | 11.7x | |
| $2.8B | 0.4x | 5.4x | |
| $2.8B | 0.7x | 6.2x | |
| $2.5B | 0.8x | 7.5x | |
| $2.3B | 1.3x | 9.4x | |
| $2.3B | 0.7x | 38.7x | |
| $2.0B | 2.5x | 7.3x | |
| $1.9B | 0.8x | 10.0x | |
| $1.4B | 0.4x | 6.1x | |
| $1.4B | 1.2x | 10.9x | |
| $1.3B | 0.5x | 9.7x | |
| $1.3B | 1.7x | 21.2x | |
| $1.2B | n/a | n/a | |
| $1.1B | n/a | n/a | |
| $1.1B | n/a | n/a | |
| $1.0B | 0.7x | 9.3x | |
| $1.0B | 0.4x | 6.3x | |
| $987M | n/a | n/a | |
| $814M | n/a | n/a | |
| $794M | 1.2x | 13.8x | |
| $707M | 0.5x | -13.5x | |
| $650M | n/a | n/a | |
| $618M | n/a | n/a | |
| $559M | 0.2x | 22.0x | |
| $292M | 0.1x | n/a | |
| $272M | n/a | n/a | |
| $212M | 0.5x | 8.5x | |
| $134M | n/a | n/a | |
| $85.2M | n/a | n/a | |
| $85.2M | 0.6x | 13.6x | |
| $53.4M | n/a | n/a | |
| $27.7M | n/a | n/a | |
| $27.3M | 0.4x | 38.5x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Pharmacies